TScan Therapeutics
TCRX
TCRX
32 hedge funds and large institutions have $73.2M invested in TScan Therapeutics in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 1 reducing their positions, and 1 closing their positions.
Holders
32
Holders Change
+4
Holders Change %
+14.29%
% of All Funds
0.51%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
10
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
BlackRock
New York
|
$4.3M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$4.49M |
| 3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$789K |
| 4 |
4
Morgan Stanley
New York
|
$664K |
| 5 |
5
Northern Trust
Chicago,
Illinois
|
$184K |
Top Sellers
| 1 |
MIM
1
Monashee Investment Management
Boston,
Massachusetts
|
$0 |
| 2 |
2
Renaissance Technologies
New York
|
$45K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AWM
26
Aries Wealth Management
Portland,
Maine
| $35.3K | 10,000 | +10,000 | New |
|
|
WPW
27
Waldron Private Wealth
Bridgeville,
Pennsylvania
| $25.6K | 10,000 | – | – |
|
28
Qube Research & Technologies (QRT)
London,
United Kingdom
| $6.17K | 2,410 | +2,410 | New |
|
29
UBS Group
Zurich,
Switzerland
| $2.85K | 1,115 | +15 | +1% |
|
|
ACA
30
Atlas Capital Advisors
Jackson,
Wyoming
| $2.29K | 896 | – | – |
|
31
Wells Fargo
San Francisco,
California
| $732 | 286 | +206 | +258% |
|
32
Bank of America
Charlotte,
North Carolina
| $512 | 200 | – | – |
|
|
MIM
33
Monashee Investment Management
Boston,
Massachusetts
| – | – | -400,000 | Closed |
|
|
CFGS
34
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|